Evidence map›Paper›PMID 36276804›Full record

ArticleAJOG global reports2022

Association between preeclampsia and HIV: a case-control study in urban South Africa.

Mpho Lerato Sikhosana, Melinda Suchard, Lazarus Kuonza, Clare Cutland, Amy Slogrove, Kennedy Otwombe, Nkengafac Villyen Motaze

Open access · goldAbstract read
In one paragraph

Article in AJOG global reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Mpho Lerato SikhosanaSouth African Field Epidemiology Training Programme, National Institute for Communicable Diseases, Johannesburg, Gauteng Province, South Africa (Drs Sikhosana and Kuonza).
Melinda SuchardCentre for Vaccines and Immunology, National Institute for Communicable Diseases, Johannesburg, Gauteng Province, South Africa (Drs Suchard and Motaze).
Lazarus KuonzaSouth African Field Epidemiology Training Programme, National Institute for Communicable Diseases, Johannesburg, Gauteng Province, South Africa (Drs Sikhosana and Kuonza).
Clare CutlandFaculty of Health Sciences, African Leadership in Vaccinology Expertise, University of the Witwatersrand, Johannesburg, Gauteng Province, South Africa (Dr Cutland).
Amy SlogroveFaculty of Medicine and Health Sciences, Department of Paediatrics and Child Health, Stellenbosch University, Worcester, Western Cape Province, South Africa (Dr Slogrove).
Kennedy OtwombeFaculty of Health Sciences, School of Public Health, University of the Witwatersrand, Johannesburg, Gauteng Province, South Africa (Dr Otwombe).
Nkengafac Villyen MotazeMedicine Usage in South Africa, School of Pharmacy, Faculty of Health Sciences, North West University, Potchefstroom, North West Province, South Africa (Dr Motaze).
University of the Witwatersrand · ZANational Institute for Communicable DiseasesStellenbosch University · ZAWestern Cape Department of Health · ZA

Funding

The effect of hypertensive disorders in pregnancy and HIV-infection on maternal, birth and infant outcomes in South AfricaK43TW010683 · FIC · STELLENBOSCH UNIVERSITY · PI SLOGROVE, AMY LOUISE · 2017 to 2021
$647k
FIC NIH HHS K43 TW010683
6 · The paper itself

Abstract

backgroundPreeclampsia is a considerable cause of maternal and infant morbidity and mortality. Although its etiology is unknown, preeclampsia has been described as a state of exaggerated maternal inflammatory response. Therefore, it has been hypothesized that preeclampsia would occur less commonly in states of immune deficiency.

objectiveThis study aimed to compare the prevalence of treated and untreated HIV infections among preeclamptic cases and controls, determine infant outcomes, and evaluate the association between HIV and preeclampsia after adjusting for known predictor variables, including maternal age, gravidity, body mass index, and smoking. STUDY

designThis case-control study investigated the association between preeclampsia and HIV infection using secondary data from an unrelated study. We defined preeclamptic cases as pregnant women who were normotensive until 20 weeks of gestation and thereafter had at least 1 high blood pressure measurement either before or at delivery and proteinuria, defined as protein excretion of ≥300 mg within 24 hours or >2 protein on dipstick urinalysis. The prevalence of HIV infection was compared between cases and controls. Multivariate logistic regression analysis was used to assess the association between preeclampsia and potential confounding variables and reported using odds ratios and 95% confidence intervals.

resultsThere were 571 cases with preeclampsia and 596 normotensive controls included in this study. The median age was 27 years for cases and 26 years for controls (

conclusionBefore the large-scale rollout of antiretroviral therapy in a setting with a high burden of HIV and preeclampsia, untreated HIV infection was found to have a protective effect against preeclampsia. The protective effect against preeclampsia was not apparent for HIV infection treated with antiretroviral therapy.

Indexed as

antiretroviral therapyHIVimmune reconstitutioninfant outcomespreeclampsia

Identifiers

PMID36276804
PMCPMC9563819
OpenAlexW4223888637

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.